Display options
Share it on

Curr Neuropharmacol. 2005 Oct;3(4):317-23. doi: 10.2174/157015905774322534.

Neuroprotection by alpha 2-adrenergic agonists in cerebral ischemia.

Current neuropharmacology

Yonghua Zhang, Harold K Kimelberg

Affiliations

  1. Neural and Vascular Biology Theme, Ordway Research Institute, 150 New Scotland Avenue, Albany, New York 12208, USA. [email protected]

PMID: 18369397 PMCID: PMC2268994 DOI: 10.2174/157015905774322534

Abstract

Ischemic brain injury is implicated in the pathophysiology of stroke and brain trauma, which are among the top killers worldwide, and intensive studies have been performed to reduce neural cell death after cerebral ischemia. Alpha 2-adrenergic agonists have been shown to improve the histomorphological and neurological outcome after cerebral ischemic injury when administered during ischemia, and recent studies have provided considerable evidence that alpha 2-adrenergic agonists can protect the brain from ischemia/reperfusion injury. Thus, alpha 2-adrenergic agonists are promising potential drugs in preventing cerebral ischemic injury, but the mechanisms by which alpha 2-adrenergic agonists exert their neuroprotective effect are unclear. Activation of both the alpha 2-adrenergic receptor and imidazoline receptor may be involved. This mini review examines the recent progress in alpha 2-adrenergic agonists - induced neuroprotection and its proposed mechanisms in cerebral ischemic injury.

Keywords: Alpha 2-adrenergic agonist; adrenoceptor; cerebral ischemia; excitatory amino acids; imidazoline receptor; neuroprotection; stroke; sympathoinhibition

References

  1. Fundam Clin Pharmacol. 1992;6 Suppl 1:23S-29S - PubMed
  2. Adv Pharmacol. 1998;42:379-90 - PubMed
  3. Ann N Y Acad Sci. 1999 Jun 21;881:114-7 - PubMed
  4. Neurosci Lett. 1995 Jan 23;184(2):133-6 - PubMed
  5. J Biol Chem. 1993 Oct 25;268(30):22235-8 - PubMed
  6. Eur J Pharmacol. 1999 Jan 29;366(1):35-9 - PubMed
  7. Brain Res. 1991 Jan 18;539(1):67-75 - PubMed
  8. J Neurosci. 1993 Dec;13(12):5393-401 - PubMed
  9. Anal Biochem. 1999 Nov 1;275(1):54-61 - PubMed
  10. Mol Pharmacol. 1996 Jul;50(1):96-103 - PubMed
  11. Anesthesiology. 1996 Sep;85(3):544-50 - PubMed
  12. Eur J Pharmacol. 1988 Dec 6;158(1-2):119-27 - PubMed
  13. Anesthesiology. 1991 Mar;74(3):581-605 - PubMed
  14. Anesthesiology. 1992 Oct;77(4):779-84 - PubMed
  15. Anesth Analg. 2003 Feb;96(2):524-31, table of contents - PubMed
  16. J Cereb Blood Flow Metab. 2000 Jun;20(6):895-8 - PubMed
  17. J Cereb Blood Flow Metab. 1992 Jan;12(1):53-63 - PubMed
  18. Anesthesiology. 1996 Sep;85(3):655-74 - PubMed
  19. Adv Cyclic Nucleotide Res. 1978;9:453-64 - PubMed
  20. Brain Res. 1988 Feb 16;441(1-2):309-18 - PubMed
  21. J Physiol. 1999 Sep 1;519 Pt 2:439-49 - PubMed
  22. Eur J Pharmacol. 1987 Jan 28;134(1):1-13 - PubMed
  23. Neuroscientist. 2002 Jun;8(3):254-67 - PubMed
  24. Rev Physiol Biochem Pharmacol. 1987;107:73-146 - PubMed
  25. Trends Pharmacol Sci. 1989 Sep;10(9):342-4 - PubMed
  26. Surg Neurol. 1998 Sep;50(3):264-70; discussion 270-1 - PubMed
  27. Eur J Pharmacol. 1998 Nov 13;361(1):1-15 - PubMed
  28. J Pharmacol Exp Ther. 1990 Jan;252(1):293-9 - PubMed
  29. Prog Clin Biol Res. 1990;361:291-9 - PubMed
  30. J Neurochem. 1993 Jan;60(1):10-23 - PubMed
  31. J Pharmacol Exp Ther. 1989 Nov;251(2):640-4 - PubMed
  32. Anesth Analg. 1991 Oct;73(4):460-4 - PubMed
  33. Neurosci Lett. 1988 Aug 15;91(1):36-40 - PubMed
  34. J Cereb Blood Flow Metab. 1989 Dec;9(6):892-6 - PubMed
  35. Brain Res. 1990 Apr 23;514(1):15-21 - PubMed
  36. Anesthesiology. 2002 Feb;96(2):450-7 - PubMed
  37. Eur J Pharmacol. 1994 Jan 1;266(1):25-33 - PubMed
  38. J Cereb Blood Flow Metab. 1989 Apr;9(2):171-4 - PubMed
  39. Neuropharmacology. 1995 Apr;34(4):357-66 - PubMed
  40. Anesthesiology. 2000 Nov;93(5):1345-9 - PubMed
  41. Stroke. 1995 Mar;26(3):503-13 - PubMed
  42. Neuroscience. 2004;125(3):625-31 - PubMed
  43. Science. 2001 May 4;292(5518):923-6 - PubMed
  44. Science. 1992 Aug 14;257(5072):977-80 - PubMed
  45. Anesthesiology. 1997 Aug;87(2):371-7 - PubMed
  46. J Cereb Blood Flow Metab. 1989 Apr;9(2):127-40 - PubMed
  47. J Cereb Blood Flow Metab. 1990 Nov;10(6):885-94 - PubMed
  48. Pharmacol Biochem Behav. 1992 Aug;42(4):693-8 - PubMed
  49. Am J Cardiol. 1994 Dec 22;74(13):25A-30A - PubMed
  50. Neuropsychopharmacology. 1995 Jul;12(4):347-9 - PubMed
  51. Anesthesiology. 1993 Aug;79(2):323-31 - PubMed
  52. Mol Pharmacol. 1990 Jan;37(1):65-8 - PubMed
  53. Pharmacol Ther. 2002 Jan;93(1):1-35 - PubMed
  54. Anesthesiology. 1994 Dec;81(6):1527-34 - PubMed
  55. J Pharmacol Exp Ther. 1995 Feb;272(2):681-8 - PubMed
  56. J Neurochem. 1998 Oct;71(4):1429-35 - PubMed
  57. Anesthesiology. 1991 Aug;75(2):328-32 - PubMed
  58. Eur J Pharmacol. 1999 May 7;372(1):31-6 - PubMed
  59. Brain Res. 1995 Sep 25;693(1-2):217-24 - PubMed
  60. Anesth Analg. 1993 Nov;77(5):877-9 - PubMed
  61. Pharmacol Rev. 1980 Dec;32(4):337-62 - PubMed
  62. Stroke. 1991 May;22(5):635-42 - PubMed
  63. Anesthesiology. 1993 Aug;79(2):306-12 - PubMed
  64. Pharmacology. 1986;32(2):109-13 - PubMed
  65. J Neurochem. 1990 Jul;55(1):192-203 - PubMed
  66. Stroke. 2002 Jul;33(7):1889-98 - PubMed
  67. Crit Care Med. 1988 Oct;16(10):954-63 - PubMed
  68. Neurochem Int. 1993 Feb;22(2):153-63 - PubMed
  69. Brain Res. 1998 Jan 19;781(1-2):202-11 - PubMed
  70. Glia. 2005 Jun;50(4):389-97 - PubMed
  71. J Pharmacol Exp Ther. 2001 Jan;296(1):216-23 - PubMed
  72. Pharmacol Rev. 1994 Jun;46(2):121-36 - PubMed
  73. J Neural Transm. 1988;71(2):133-42 - PubMed
  74. Acta Neuropathol. 1988;75(3):295-307 - PubMed
  75. Anesthesiology. 2002 Jan;96(1):134-41 - PubMed
  76. J Neurosurg Anesthesiol. 1996 Jul;8(3):230-6 - PubMed
  77. Trends Pharmacol Sci. 1996 Jan;17(1):13-6 - PubMed
  78. Anesthesiology. 1996 Sep;85(3):551-7 - PubMed

Publication Types